ZLC491, CAS [[3053716-46-1]]

Produktübersicht

• Artikelname: ZLC491, CAS [[3053716-46-1]]
• Artikelnummer: MCE-HY-168162
• Hersteller Artikelnummer: HY-168162
• Alternativnummer: MCE-HY-168162-50MG,MCE-HY-168162-10MG,MCE-HY-168162-5MG,MCE-HY-168162-25MG,MCE-HY-168162-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

ZLC491 is an orally active PROTAC degrader that selectively targets CDK12/CDK13 and exhibits certain oral bioavailability. ZLC491 induces cereblon- and proteasome-dependent selective degradation of CDK12 and CDK13. ZLC491 inhibits the transcription and expression of long genes, and mainly acts on a subset of DNA damage response genes. ZLC491 inhibits the proliferation of various triple-negative breast cancer cells. ZLC491 can be used in research related to triple-negative breast cancer[1][2].

Produkteigenschaften

• Molekulargewicht: 866.98
• Reinheit: 98.51
• CAS Nummer: [3053716-46-1]
• Formel: C48H51FN10O5
• Target-Kategorie: CDK,PROTACs

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound